New Drugs news from FierceBiotech
News
J&J psoriasis drug may carry cancer risk
Outside experts are preparing to review ustekinumab, Centocor's injectable treatment of severe psoriasis. Two Phase III studies demonstrated Read more...
GSK outlines plans to become more ‘biotech-like’
Biotech is in. At least, that's the message from GlaxoSmithKline's Patrick Vallance, the pharma giant's head Read more...
Genetic mutation will narrow target cancer groups
The K-ras gene is coming in for some star treatment at the ASCO meeting in Chicago. The gene plays a key role in several cancers, and new research indicates that the common genetic mutation makes Read more...
Eli Lilly shakes up R&D ops in restructuring
Eli Lilly has shaken up the management structure of its R&D and international operations as it looks for a more efficient way to speed new drugs through the approval process. Its worldwide Read more...
GSK's Garnier: FDA raised the bar for new drugs
In an interview with the Financial Times, outgoing GSK CEO Jean-Pierre Garnier shares his thought on the new, tougher FDA approval environment. While many drug developers hope the FDA's reticence Read more...
1,300 new hires planned for FDA expansion
The FDA is hiring some 1,300 badly-needed workers to help with drug Read more...
SPOTLIGHT: Biocon establishing R&D sub
India's Biocon says it will transfer four molecules to a new R&D subsidiary, resisting a trend in the subcontinent of spinning off R&D into a new company. Its researchers are working on new Read more...
FDA approves Wyeth, Progenics drug
There's a big sigh of relief coming from Wyeth and Progenics today as the FDA approved Relistor, a subcutaneous injection for opioid-induced constipation in patients with advanced illness who are Read more...
SPOTLIGHT: Colorado passes $26.5M biotech incentive bill
Like so many other regions, Colorado is hoping to get its own slice of the biotech Read more...
Wyeth, Elan suspend Alzheimer's vaccine study
Wyeth and Elan have suspended dosing patients in a mid-stage study of the experimental Alzheimer's vaccine ACC-001 after seeing one of the patients in the study develop skin lesions. Studies of Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends